跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 惠亭
副教授
藥學系
電話
(02)2826-7157
電子郵件
htchen1969
nycu.edu
tw
網站
https://pharmacy.ym.edu.tw/ezfiles/284/1284/img/1918/701554848.pdf
h-index
h10-index
h5-index
1659
引文
20
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
226
引文
10
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
45
引文
4
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1998 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(55)
類似的個人檔案
(4)
指紋
查看啟用 Hui-Ting Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Dendrimer
100%
Polyamidoamine (PAMAM)
68%
Solid-phase Synthesis
52%
Resin
41%
Hydrolysis
39%
Melamine
29%
Quinazolin
29%
Percentage Yield
28%
Calcium Phosphate
26%
Simvastatin
26%
Hydroxyapatite
23%
Cytotoxicity
23%
Binding Affinity
23%
Hydroxyapatite Powder
21%
Lysine
21%
Pyridine
21%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
19%
Calcium Hydrogen Phosphate
19%
Chemical nuclease
19%
Crystallization
19%
Biocompatibility
19%
Calcination
19%
Copper Complex
19%
Mesenchymal Stem Cells
19%
Benzotriazole
19%
Linker
19%
Dynamic Covalent
19%
Boronate Ester
19%
Human Mesenchymal Stem Cells (hMSCs)
19%
Boronic Acid
17%
X Ray Diffraction
16%
Functional Groups
16%
PAMAM Dendrimer
16%
Silica
14%
Low Temperature
14%
Aryl
14%
Iodide
14%
Triazine Dendrimer
14%
Hydrolysis Method
14%
Branched Peptides
14%
Chondroinductive Peptides
14%
Apoptosis
14%
Microstructure
14%
Adipogenesis
14%
Dendron
14%
Therapeutic Agents
13%
Drug Toxicity
13%
Ligation
13%
Amine nucleophile
13%
One-step Method
13%
Pharmacology, Toxicology and Pharmaceutical Science
Dendrimer
76%
Poly(amidoamine)
41%
Melamine
29%
Cytotoxicity
26%
Hydroxyapatite
23%
Quinazoline
19%
Osteoarthritis
19%
Simvastatin
14%
Amino Acid
14%
Drug Toxicity
13%
Cuprous Ion
9%
Anabasine
9%
Castration Resistant Prostate Cancer
9%
Surfactant
9%
C Peptide
9%
Bovine Serum Albumin
9%
Green Fluorescent Protein
9%
Inducible Nitric Oxide Synthase
9%
Lactam
9%
Uracil
9%
Crystallization
9%
Nanocomposite
9%
Nuclease
9%
Piperidine
9%
Glycolic Acid
9%
Biocompatibility
9%
Epigallocatechin Gallate
9%
Calcium Pyrophosphate
9%
4 Pyridone Derivative
9%
Calcium Phosphate
9%
Hyaluronic Acid
9%
Quinazoline Derivative
9%
Diketone
9%
2 Aminobenzamide
9%
Statin (Protein)
9%
Boronic Acid Derivative
9%
Cetrimonium Bromide
9%
Hydrazide
9%
Prostate Cancer
9%
Nucleophile
9%
Zebra Fish
9%
Fluorine 18
9%
Calcium Phosphate Dibasic
9%
Peroxisome Proliferator Activated Receptor Gamma
9%
Controlled Release
9%
Bone Defect
9%
Polyethylene Terephthalate
9%
Aspartic Acid
9%
Hydrogen Bond
9%
Multidrug Resistance
9%